Mayo Clinic Labs
  • MayoACCESS
  • MayoLINK
  • Register
  • My Dashboard
  • Algorithms
  • Download Test Catalog & Interpretive Handbook
  • New Tests
  • NY State Informed Consent Tests
  • Performing Locations
  • Referred Tests
  • Specialty Testing
  • Test Updates
  • Critical Values & Results
  • Custom Gene Ordering
  • Forms
  • LIS Resources
  • MayoACCESS Resources
  • MayoLINK Resources
  • Order Your First Test
  • Patient Information and Signature Forms
  • Request Additional Testing
  • Send Additional Specimen
  • Collection & Preparation
  • Dangerous Goods Training
  • Shipping & Courier Guides
  • Shipping Regulations
  • Supplies
  • Billing
  • Contact Us
  • FAQ
  • IT Updates
  • Operational Updates
  • Quality & Compliance
  • Educational Resources
  • News
  • Outreach
  • Podcasts
  • Stories
  • Contact
  • Log Out
Insights
  • Education
  • News
  • Podcasting
  • Stories
A journey to diagnosis: One patient’s story of resilience and hope

For many, the path to a correct diagnosis can be long and filled with uncertainty. This story highlights the resilience and determination of one patient who navigated a complex medical journey to find answers and hope at Mayo Clinic. The patient asked to remain anonymous for personal privacy reasons.

May 5, 2025
How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D.
July 3, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, share insights from industry news and recent conferences, including PlatforMed.

Labile Copper Test Enhances Evaluation for Wilson’s Disease: Joshua Bornhorst, Ph.D.
July 1, 2025

Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' labile copper assay (Mayo ID: LBCS) improves upon standard blood tests for Wilson's disease. The new assay measures not just overall copper but also the fraction of copper that is bioavailable, or labile bound.

Neurodegenerative Diseases: Diagnostic Advancements
July 1, 2025

For healthcare professionals seeking to enhance their understanding of the assessment and treatment options for patients with neurodegenerative diseases.

The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.
February 27, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, for a conversation about innovation in testing for sexually transmitted infections (STI).

Integration, innovation, precision: Propelling leading-edge diagnostics
February 26, 2025

The third episode of “Life of a Specimen” video series discusses the integration that drives the development of innovative tests, including the movement disorders evaluation, at Mayo Clinic Laboratories.

Elevating Your Customer Service
February 24, 2025

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by colleagues Ellen Dijkman Dulkes and Brianne Newton. They discuss strategies for delivering excellent customer service.

The specimen’s journey to the laboratory: Refined processes, superior quality, unwavering care
February 19, 2025

Check out the second episode of “Life of a Specimen,” a video exploration of the complex path taken by patient samples through testing at Mayo Clinic Laboratories. In this episode, we hear about the quality processes and careful treatment given to each sample received for testing.

Winter Storm Kingston
February 18, 2025

Due to weather affecting the FedEx hub in Memphis, TN, FedEx has initiated its contingency plan and expects delays. Mayo Clinic Laboratories’ Global Logistics team will proactivelymove work from FedEx to other commercial shipping options.

Three core elements of exceptional customer service
February 17, 2025

Excellent customer service flows from three foundational elements: organizational alignment, engaged employees, and the right systems and facilities.

Monitoring winter storms
February 14, 2025

Mayo Clinic Laboratories is monitoring and tracking back-to-back winter storms moving through the Midwest and East Coast to minimize challenges. Engagement with our logistics partners is underway to minimize challenges. If any routes are modified or canceled, clients in the affected areas will be contacted directly.

Case Studies in Laboratory Safety
April 8, 2025

PACE/State of FL - This webinar will provide a review of several real-life laboratory safety events. The presentation will outline the scenarios, the lessons learned and look at ways future incidents can be prevented. We will also discuss ways to create effective corrective and preventive action plans.

Why a Quality Management Program is Essential: Bill Morice, M.D., Ph.D.
February 13, 2025

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, for a conversation about quality management.

Saving and improving lives: The illuminating journey of a laboratory testing specimen
February 12, 2025

Check out the first episode of “Life of a Specimen,” a video series that examines the critical journey taken by patient samples through Mayo Clinic Laboratories testing. In this video, we learn about the profound impact of our testing on one extraordinary patient.

Mary Jo Williamson shares strategic investment insights with Modern Healthcare
February 11, 2025

Mary Jo Williamson, chief administrative officer of Mayo Clinic Laboratories, shares insights on balancing needs with future-oriented investments.

Froedtert and the Medical College of Wisconsin: Promoting laboratory stewardship through clinical decision support
February 10, 2025

An order-entry, clinical decision support tool developed by physicians and scientists at Froedtert and the Medical College of Wisconsin (MCW) for clinicians within the healthcare system who order autoimmune and paraneoplastic antibody panels has significantly improved test utilization, resulting in a 28% reduction in monthly test volumes of impacted tests.

View MoreView Less
Mayo Clinic Labs
Mayo Clinic Labs
  • Mayo Clinic
  • About us
  • BioPharma
  • Cardiovascular services
  • Newsroom
Resources
  • FAQ
  • Policies
  • Quality
  • Careers
  • Insights
  • Terms of use
  • Privacy statement
Accounts
  • Mayo account
  • MayoLINK
  • Register
  • Dashboard
  • Log out
Contacts
  • Contacts
  • Customer service
Facebook Twitter Instagram LinkedIn YouTube
© 1995–2025 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.